Specifically, among studies focusing on myocardial infarctions or strokes as outcomes, the use of TNF-alpha inhibitors was associated with a 41% relative risk reduction in myocardial infarctions and a 43% reduction in strokes. Here, TNF is linked to myocardial infarction.